{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:23:50Z","timestamp":1791869030892,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T00:00:00Z","timestamp":1726012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.eururo.2024.09.006","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T23:08:56Z","timestamp":1728342536000},"page":"60-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3604-1990","authenticated-orcid":false,"given":"Robert","family":"Huddart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaista","family":"Hafeez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananya","family":"Choudhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Syndikus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Hindson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"McNair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Birtle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohini","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan B","family":"McLaren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omi","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Nikapota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Miles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karole","family":"Warren-Oseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Kron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Philipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Vassallo-Bonner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka Ching","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Gribble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2024.09.006_b0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","article-title":"Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis","volume":"24","author":"Zlotta","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0010","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.ijrobp.2016.08.023","article-title":"Quality of life in long-term survivors of muscle-invasive bladder cancer","volume":"96","author":"Mak","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2024.09.006_b0015","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.ijrobp.2009.12.003","article-title":"Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer","volume":"79","author":"Lalondrelle","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2024.09.006_b0020","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clon.2021.03.023","article-title":"Image-guided adaptive radiotherapy for bladder cancer","volume":"33","author":"Kong","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2024.09.006_b0025","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.clon.2013.06.001","article-title":"Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation","volume":"25","author":"McDonald","year":"2013","journal-title":"Clin Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.ijrobp.2015.12.379","article-title":"Prospective study delivering simultaneous integrated high-dose tumor boost (\u226470\u00a0Gy) with image guided adaptive radiation therapy for radical treatment of localized muscle-invasive bladder cancer","volume":"94","author":"Hafeez","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2024.09.006_b0035","doi-asserted-by":"crossref","first-page":"e041005","DOI":"10.1136\/bmjopen-2020-041005","article-title":"Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance","volume":"10","author":"Hafeez","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/j.eururo.2024.09.006_b0040","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.tipsro.2022.01.002","article-title":"Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy","volume":"21","author":"Webster","year":"2022","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0045","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.clon.2020.07.001","article-title":"Failing to close the gap between evidence and clinical practice in radical bladder cancer radiotherapy","volume":"33","author":"Hafeez","year":"2021","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2024.09.006_b0050","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.clon.2023.05.002","article-title":"Acute toxicity of hypofractionated and conventionally fractionated (chemo)radiotherapy regimens for bladder cancer: an exploratory analysis from the RAIDER trial","volume":"35","author":"Huddart","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2024.09.006_b0055","series-title":"Improving outcomes in urological cancers: the manual","author":"National Institute for Health and Care Excellence","year":"2002"},{"key":"10.1016\/j.eururo.2024.09.006_b0060","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1023\/A:1023422208910","article-title":"Multinational study of reliability and validity of the King's Health Questionnaire in patients with overactive bladder","volume":"12","author":"Reese","year":"2003","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2024.09.006_b0065","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.eururo.2024.09.006_b0070","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/sj.bjc.6602552","article-title":"A modified inflammatory bowel disease questionnaire and the Vaizey incontinence questionnaire are simple ways to identify patients with significant gastrointestinal symptoms after pelvic radiotherapy","volume":"92","author":"Olopade","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.eururo.2024.09.006_b0075","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1016\/j.clon.2016.06.004","article-title":"The three-item ALERT-B questionnaire provides a validated screening tool to detect chronic gastrointestinal symptoms after pelvic radiotherapy in cancer survivors","volume":"28","author":"Taylor","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2024.09.006_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.eururo.2024.09.006_b0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ijrobp.2003.10.018","article-title":"Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy","volume":"59","author":"Cowan","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2024.09.006_b0090","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2011.01.027","article-title":"'Plan of the day' adaptive radiotherapy for bladder cancer using helical tomotherapy","volume":"99","author":"Murthy","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0095","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.ijrobp.2013.06.2044","article-title":"Randomized noninferiority trial of reduced high-dose volume versus standard volume radiation therapy for muscle-invasive bladder cancer: results of the BC2001 trial (CRUK\/01\/004)","volume":"87","author":"Huddart","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.eururo.2024.09.006_b0100","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1200\/JCO.2010.28.4950","article-title":"Radiotherapy with concurrent carbogen and nicotinamide in bladder carcinoma","volume":"28","author":"Hoskin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0105","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1200\/JCO.2008.19.5776","article-title":"Late pelvic toxicity after bladder-sparing therapy in patients with invasive bladder cancer: RTOG 89\u201303, 95\u201306, 97\u201306, 99\u201306","volume":"27","author":"Efstathiou","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0110","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2016.09.006","article-title":"Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: a pooled individual data analysis of eight phase I-II trials","volume":"121","author":"Caffo","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0115","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.radonc.2014.08.019","article-title":"Inter- and intra-fractional bladder motion during radiotherapy for bladder cancer: a comparison of full and empty bladders","volume":"113","author":"Dees-Ribbers","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0120","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.clon.2014.03.007","article-title":"Comparison of margins, integral dose and interfraction target coverage with image-guided radiotherapy compared with non-image-guided radiotherapy for bladder cancer","volume":"26","author":"Foroudi","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.eururo.2024.09.006_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110460","article-title":"Impact of on-trial IGRT quality assurance in an international adaptive radiotherapy trial for participants with bladder cancer","volume":"199","author":"Webster","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0130","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1106106","article-title":"Radiotherapy with or without chemotherapy in muscle-invasive bladder cancer","volume":"366","author":"James","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.eururo.2024.09.006_b0135","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1200\/JCO.2017.35.6_suppl.280","article-title":"BC2001 long term outcomes: a phase III randomised trial of chemo-radiotherapy versus radiotherapy (RT) alone and standard RT versus reduced high-dose volume RT in muscle invasive bladder cancer","volume":"35","author":"Hall","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.eururo.2024.09.006_b0140","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.eururo.2016.12.020","article-title":"Long-term outcomes after bladder-preserving tri-modality therapy for patients with muscle-invasive bladder cancer: an updated analysis of the Massachusetts General Hospital experience","volume":"71","author":"Giacalone","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2024.09.006_bib141","article-title":"Bladder tumour focused adaptive radiotherapy: Clinical outcomes of a phase I dose escalation study","author":"Hafeez","year":"2024","journal-title":"International Journal of Radiation Oncology*Biology*Physics"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382402596X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030228382402596X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T22:36:29Z","timestamp":1741905389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030228382402596X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S030228382402596X"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2024.09.006","relation":{},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dose-escalated Adaptive Radiotherapy for Bladder Cancer: Results of the Phase 2 RAIDER Randomised Controlled Trial","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2024.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.","name":"copyright","label":"Copyright"}]}}